4Filing Date: Aug 20, 2026
Incyte
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001205703-26-000028
Total Value$1.36M
Trades1
Insiders1
Transaction Details
CAGNONI PABLO J
President, Global Head of R&D·Direct
Sell · Dispose
Common Stock
Shares-10.80K
Price$125.56
Total Value$1.36M
Shares Owned After183.20K
Transaction DateAug 19, 2026
10b5-1
Footnotes ▸
This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
Post-Transaction Holdings
CAGNONI PABLO J · President, Global Head of R&D
| Security | Shares | Change |
|---|---|---|
| Common Stock | 183.20K | -10.80K (-5.57%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-08-19
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: INCYTE CORP (INCY)
CIK: 0000879169
--- Reporting Owner ---
Name: CAGNONI PABLO J
CIK: 0001205703
Role: Officer (President, Global Head of R&D)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-08-19 | Code: S (Open market sale)
Shares: -10,801 | Price: $125.56
Total Value: $1,356,173.56
Shares Owned After: 183,200 | Ownership: D (Direct)
Footnotes:
[F1] This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
--- Footnotes (Complete Index) ---
F1: This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
--- Signature ---
/s/ /s/ Elizabeth Feeney, Attorney-In-Fact (2026-08-20)